Examkin

Question

Difficulty: HardBreast and Endocrine Surgery

A 5656-year-old woman is referred to the surgical clinic due to asymptomatic hypercalcemia discovered during a routine wellness examination. Laboratory studies reveal a serum calcium level of 11.211.2 mg/dL (normal: 8.48.4-10.210.2 mg/dL) and an intact parathyroid hormone (PTH) level of 118118 pg/mL (normal: 1010-6565 pg/mL). Her serum creatinine and 2525-hydroxyvitamin D levels are within normal limits. Bone densitometry demonstrates a T-score of −2.6-2.6 at the lumbar spine. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

  1. 1Measurement of 2424-hour urinary calcium-to-creatinine clearance ratio
  2. 2Preoperative localization with cervical ultrasonography and sestamibi scintigraphy
  3. 3Surgical exploration and excision of the suspected parathyroid adenoma
  4. 4Confirmation of surgical cure via intraoperative parathyroid hormone (PTH) assay
  5. 5Postoperative monitoring for hypocalcemia and perioral paresthesias

Answer

The correct chronological sequence is: Measurement of 24-hour urinary calcium-to-creatinine clearance ratio, followed by Preoperative localization with cervical ultrasonography and sestamibi scintigraphy, then Surgical exploration and excision of the suspected parathyroid adenoma, Confirmation of surgical cure via intraoperative parathyroid hormone (PTH) assay, and finally Postoperative monitoring for hypocalcemia and perioral paresthesias.
The management of primary hyperparathyroidism follows a strict algorithm to prevent unnecessary or unsuccessful operations. First, the biochemical diagnosis is solidified by documenting elevated calcium and inappropriately elevated PTH. Second, FHH must be excluded using the 2424-hour urine calcium test, as surgery is contraindicated in FHH. Third, once surgery is indicated (e.g., due to the patient's osteoporosis), localization studies (ultrasound, sestamibi) are obtained to facilitate a focused, minimally invasive procedure. Fourth, during the operation, the suspected adenoma is excised, and intraoperative PTH is drawn 1010 minutes later to confirm a >50%>50\% drop, ensuring all hyperfunctioning tissue was removed. Finally, postoperative monitoring is essential to catch transient hypocalcemia as the remaining suppressed parathyroid tissue slowly recovers.

Step-by-Step Solution

1
Recognize the biochemical diagnosis of primary hyperparathyroidism and indications for surgery.
The patient has elevated calcium, elevated PTH, and osteoporosis (T-score ≤−2.5\leq -2.5), meeting surgical criteria.
Establishing the biochemical diagnosis and surgical indication is the prerequisite for all subsequent steps.
2
Rule out Familial Hypocalciuric Hypercalcemia (FHH).
Order a 2424-hour urinary calcium-to-creatinine clearance ratio.
FHH mimics primary hyperparathyroidism biochemically but is managed medically; parathyroidectomy is strictly contraindicated. This must be ruled out before proceeding to imaging.
3
Plan the surgical approach.
Perform preoperative localization using cervical ultrasonography and technetium-99m sestamibi scintigraphy.
Localization studies are NOT diagnostic tests; they are surgical planning tools used only after the biochemical diagnosis is secure to allow for minimally invasive parathyroidectomy instead of bilateral neck exploration.
4
Perform the surgical intervention and confirm adequate resection.
Excise the adenoma and measure intraoperative PTH (IOPTH) levels.
Due to the short half-life of PTH (33-55 minutes), a decline of >50%>50\% from baseline at 1010 minutes post-excision confirms that no additional hyperfunctioning glands remain (Miami criteria).
5
Manage the patient in the immediate postoperative period.
Monitor serum calcium and assess for clinical signs of hypocalcemia (e.g., Chvostek sign, perioral numbness).
The remaining normal parathyroid glands are chronically suppressed, and patients can develop transient hypocalcemia or hungry bone syndrome requiring calcium and vitamin D supplementation.

Key Concept

The precise chronological sequencing of primary hyperparathyroidism management requires strict adherence to biochemical confirmation (including ruling out FHH) prior to anatomical localization and surgical intervention.
Rate this question

Topics

Breast and Endocrine Surgery

More questions from this topic